Cerebrospinal fluid τ and β-amyloid(1-42) in dementia disorders
- 30 November 2001
- journal article
- review article
- Published by Elsevier in Mechanisms of Ageing and Development
- Vol. 122 (16) , 2005-2011
- https://doi.org/10.1016/s0047-6374(01)00304-9
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Evaluation of CSF-tau and CSF-Aβ42 as Diagnostic Markers for Alzheimer Disease in Clinical PracticeArchives of Neurology, 2001
- Amyloid Aβ40 CSF concentrations correlate to frontal lobe atrophy in frontotemporal dementiaNeuroReport, 2000
- Cerebrospinal fluid tau and Aβ42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairmentNeuroscience Letters, 1999
- Cerebrospinal Fluid β-Amyloid(1-42) in Alzheimer DiseaseArchives of Neurology, 1999
- Improved discrimination of AD patients using β-amyloid (1-42) and tau levels in CSFNeurology, 1999
- Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's diseaseNeuroscience Letters, 1998
- High Cerebrospinal Fluid Tau and Low Amyloid β42 Levels in the Clinical Diagnosis of Alzheimer Disease and Relation to Apolipoprotein E GenotypeArchives of Neurology, 1998
- Cerebrospinal Fluid Tau Levels in Neurodegenerative Diseases with Distinct Tau-Related PathologyBiochemical and Biophysical Research Communications, 1997
- Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's diseaseNeurology, 1997
- tau protein in cerebrospinal fluidMolecular and Chemical Neuropathology, 1995